Fledgling universities funded by kings and other leaders hired professors for their chemistry departments. Organic chemistry became a recognized discipline. These developments established an entirely ...

Abstract: Autism spectrum disorder is a complex neurodevelopmental disorder with a strong hereditary construct that requires the development of novel treatment strategies. This study focuses on ...

Aurora Therapeutics' first target is the rare inherited disease phenylketonuria, also known as PKU. Here at MIT Technology Review we’ve been writing about the gene-editing technology CRISPR since 2013 ...

Plus: Grok is restricting its image-generating function to paid subscribers only This is today's edition of The Download, our weekday newsletter that provides a daily dose of what's going on in the ...

A new CRISPR breakthrough shows scientists can turn genes back on without cutting DNA, by removing chemical tags that act like molecular anchors. The work confirms these tags actively silence genes, ...

CRISPR biosensors are transforming healthcare by detecting biomarkers at attomolar sensitivity, enabling real-time health monitoring through wearable patches and implantable sensors. They continuously ...

Researchers have successfully resurrected a gene that humanity lost millions of years ago. The results could change how we treat common diseases such as gout and maybe even contribute to slowing down ...

Chicago-based CRISPR technology company Syntax Bio says it has developed tech that automates the slow, manual process of generating functional cell types, which may usher in a new generation of cell ...

Crops around the world are under pressure from high temperatures, unpredictable weather patterns and disease. Something must be done to protect them. Gene editing in agriculture can make crops more ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in Science Advances detailing the company's CRISPR-based Cellgorithm technology, ...

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of new research in Science Advances detailing the company's CRISPR-based ...

Utilizing the gene-editing technology CRISPR, researchers have found a way to combat chemoresistance in lung cancer cells, restoring hope for patients. Shannon Horning/ SciTech Editor For patients ...